AAREY DRUGS & PHARMACEUTICALS
|
AAREY DRUGS & PHARMACEUTICALS Last 5 Year Income Statement History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹398 Cr | ₹419 Cr | ₹493 Cr | ₹34,841,641 Cr | ₹300 Cr |
| Sales | ₹396 Cr | ₹414 Cr | ₹493 Cr | ₹34,841,641 Cr | ₹300 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | ₹2.03 Cr | - | - | - | - |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | - | ₹4.70 Cr | ₹0.08 Cr | - | - |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹398 Cr | ₹419 Cr | ₹493 Cr | ₹34,841,641 Cr | ₹300 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-5.86 Cr | ₹-15 Cr | ₹4.77 Cr | ₹-146,460 Cr | ₹4.25 Cr |
| Raw Material Consumed | ₹381 Cr | ₹413 Cr | ₹461 Cr | ₹33,596,012 Cr | ₹286 Cr |
| Opening Raw Materials | - | - | - | - | - |
| Purchases Raw Materials | - | - | - | - | - |
| Closing Raw Materials | - | - | - | - | - |
| Other Direct Purchases / Brought in cost | ₹381 Cr | ₹413 Cr | ₹461 Cr | ₹33,596,012 Cr | ₹286 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹0.03 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹287 Cr | ₹0.02 Cr |
| Electricity & Power | ₹0.03 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹287 Cr | ₹0.02 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹0.54 Cr | ₹0.63 Cr | ₹0.67 Cr | ₹19,818 Cr | ₹0.29 Cr |
| Salaries, Wages & Bonus | ₹0.49 Cr | ₹0.58 Cr | ₹0.59 Cr | ₹12,283 Cr | ₹0.26 Cr |
| Contributions to EPF & Pension Funds | ₹0.01 Cr | ₹0.01 Cr | - | - | - |
| Workmen and Staff Welfare Expenses | ₹0.04 Cr | ₹0.03 Cr | ₹0.08 Cr | ₹3,807 Cr | ₹0.02 Cr |
| Other Employees Cost | - | - | - | ₹3,729 Cr | ₹0.02 Cr |
| Other Manufacturing Expenses | ₹11 Cr | ₹7.94 Cr | ₹8.47 Cr | ₹499,715 Cr | ₹1.56 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | - | - | - | - | - |
| Repairs and Maintenance | - | - | - | - | - |
| Packing Material Consumed | - | - | - | - | - |
| Other Mfg Exp | ₹11 Cr | ₹7.94 Cr | ₹8.47 Cr | ₹499,715 Cr | ₹1.56 Cr |
| General and Administration Expenses | ₹2.47 Cr | ₹3.08 Cr | ₹3.42 Cr | ₹197,238 Cr | ₹1.38 Cr |
| Rent , Rates & Taxes | ₹1.07 Cr | ₹1.99 Cr | ₹1.80 Cr | ₹120,160 Cr | ₹0.53 Cr |
| Insurance | ₹0.06 Cr | ₹0.05 Cr | ₹0.15 Cr | ₹14,042 Cr | ₹0.28 Cr |
| Printing and stationery | ₹0.03 Cr | ₹0.03 Cr | ₹0.05 Cr | ₹1,604 Cr | ₹0.02 Cr |
| Professional and legal fees | ₹1.00 Cr | ₹0.61 Cr | ₹0.72 Cr | ₹22,665 Cr | ₹0.17 Cr |
| Traveling and conveyance | ₹0.02 Cr | ₹0.06 Cr | ₹0.17 Cr | ₹6,968 Cr | ₹0.09 Cr |
| Other Administration | ₹0.30 Cr | ₹0.34 Cr | ₹0.53 Cr | ₹31,798 Cr | ₹0.28 Cr |
| Selling and Distribution Expenses | ₹1.23 Cr | ₹1.31 Cr | ₹2.15 Cr | ₹186,180 Cr | ₹3.37 Cr |
| Advertisement & Sales Promotion | ₹0.17 Cr | ₹0.26 Cr | ₹0.39 Cr | ₹15,853 Cr | ₹0.20 Cr |
| Sales Commissions & Incentives | ₹0.90 Cr | - | - | - | - |
| Freight and Forwarding | ₹0.05 Cr | ₹0.12 Cr | ₹0.20 Cr | ₹7,008 Cr | ₹0.11 Cr |
| Handling and Clearing Charges | ₹0.04 Cr | ₹0.03 Cr | ₹0.09 Cr | ₹1,711 Cr | ₹0.02 Cr |
| Other Selling Expenses | ₹0.07 Cr | ₹0.91 Cr | ₹1.47 Cr | ₹161,608 Cr | ₹3.05 Cr |
| Miscellaneous Expenses | ₹0.26 Cr | ₹0.71 Cr | ₹0.51 Cr | ₹23,795 Cr | ₹0.06 Cr |
| Bad debts /advances written off | - | - | - | - | - |
| Provision for doubtful debts | - | - | - | - | - |
| Losson disposal of fixed assets(net) | - | - | - | - | - |
| Losson foreign exchange fluctuations | ₹0.05 Cr | ₹0.45 Cr | ₹0.11 Cr | - | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹0.21 Cr | ₹0.26 Cr | ₹0.39 Cr | ₹23,795 Cr | ₹0.06 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹391 Cr | ₹411 Cr | ₹481 Cr | ₹34,376,585 Cr | ₹297 Cr |
| Operating Profit (Excl OI) | ₹6.48 Cr | ₹7.72 Cr | ₹11 Cr | ₹465,056 Cr | ₹3.23 Cr |
| Other Income | ₹4.94 Cr | ₹2.73 Cr | ₹2.67 Cr | ₹701,463 Cr | ₹6.69 Cr |
| Interest Received | ₹4.87 Cr | ₹2.63 Cr | ₹2.01 Cr | ₹242,876 Cr | ₹2.66 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | - | - | - | - | - |
| Profits on sale of Investments | - | - | - | - | - |
| Provision Written Back | - | - | - | - | - |
| Foreign Exchange Gains | ₹0.05 Cr | - | ₹0.15 Cr | ₹385 Cr | - |
| Others | ₹0.01 Cr | ₹0.10 Cr | ₹0.51 Cr | ₹458,202 Cr | ₹4.03 Cr |
| Operating Profit | ₹11 Cr | ₹10 Cr | ₹14 Cr | ₹1,166,519 Cr | ₹9.92 Cr |
| Interest | ₹4.38 Cr | ₹2.87 Cr | ₹2.04 Cr | ₹244,339 Cr | ₹1.79 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | ₹0.30 Cr | ₹0.32 Cr | ₹1.63 Cr | ₹221,906 Cr | ₹1.66 Cr |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | ₹0.18 Cr | ₹0.33 Cr | ₹0.22 Cr | ₹21,253 Cr | ₹0.10 Cr |
| Other Interest | ₹3.90 Cr | ₹2.22 Cr | ₹0.19 Cr | ₹1,180 Cr | ₹0.03 Cr |
| PBDT | ₹7.04 Cr | ₹7.58 Cr | ₹12 Cr | ₹922,180 Cr | ₹8.14 Cr |
| Depreciation | ₹1.70 Cr | ₹1.57 Cr | ₹1.99 Cr | ₹92,042 Cr | ₹0.89 Cr |
| Profit Before Taxation & Exceptional Items | ₹5.34 Cr | ₹6.01 Cr | ₹10 Cr | ₹830,138 Cr | ₹7.24 Cr |
| Exceptional Income / Expenses | - | - | - | - | - |
| Profit Before Tax | ₹5.34 Cr | ₹6.01 Cr | ₹10 Cr | ₹830,138 Cr | ₹7.24 Cr |
| Provision for Tax | ₹0.66 Cr | ₹2.24 Cr | ₹3.48 Cr | ₹178,707 Cr | ₹1.45 Cr |
| Current Income Tax | ₹1.33 Cr | ₹1.78 Cr | ₹2.61 Cr | ₹166,400 Cr | ₹1.50 Cr |
| Deferred Tax | ₹-0.67 Cr | ₹-0.04 Cr | ₹-0.11 Cr | ₹12,307 Cr | ₹-0.05 Cr |
| Other taxes | - | ₹0.50 Cr | ₹0.98 Cr | - | - |
| Profit After Tax | ₹4.68 Cr | ₹3.77 Cr | ₹6.56 Cr | ₹651,431 Cr | ₹5.79 Cr |
| Extra items | - | - | - | - | - |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹48 Cr | ₹45 Cr | ₹38 Cr | ₹3,159,427 Cr | ₹26 Cr |
| Appropriations | ₹53 Cr | ₹48 Cr | ₹45 Cr | ₹3,810,857 Cr | ₹32 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | - | - | - | - | - |
| Equity Dividend % | - | - | - | - | - |
| Earnings Per Share | ₹1.67 | ₹1.49 | ₹2.58 | ₹2.79 | ₹2.48 |
| Adjusted EPS | ₹1.67 | ₹1.49 | ₹2.58 | ₹2.79 | ₹2.48 |
Compare Income Statement of peers of AAREY DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AAREY DRUGS & PHARMACEUTICALS | ₹188.7 Cr | -13.1% | -30.2% | 5.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,536.0 Cr | 0.1% | 4.3% | -1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,753.0 Cr | -0.6% | -1.3% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,650.0 Cr | 0.5% | -0.6% | 13.7% | Stock Analytics | |
| CIPLA | ₹122,143.0 Cr | -0.6% | -0.5% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,244.0 Cr | -0.2% | 3.6% | -0.3% | Stock Analytics | |
AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AAREY DRUGS & PHARMACEUTICALS | -13.1% |
-30.2% |
5.3% |
| SENSEX | -0.5% |
1.1% |
3.8% |
You may also like the below Video Courses